ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/Cell-permeable Caspase-1 Inhibitor I trifluoroacetate salt
C99H161F3N20O26
2104.5 g/mol
Research Reagent

Cell-permeable Caspase-1 Inhibitor I trifluoroacetate salt

CAS201608-12-0
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

This compound is a cell-permeable peptide aldehyde that functions as a selective inhibitor of caspase-1, used as a research tool to study inflammasome-related pathways. It is supplied as a trifluoroacetate salt and is intended for laboratory research purposes only.

Investigating caspase-1 activity in cellular signalingResearch tool for inflammasome mechanism studies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Cell-permeable Caspase-1 Inhibitor I trifluoroacetate salt?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

Cumyl dithiobenzoate

CAS201611-77-0

research compound

ReferenceSame Category

Cyanoisopropyl dithiobenzoate

CAS201611-85-0

research compound

ReferenceSame Category

4-Cyano-4-(thiobenzoylthio)pentanoic acid

CAS201611-92-9

research compound

ReferenceSame Category

2-Bromo-9,10-diphenylanthracene

CAS201731-79-5

research compound

Referencesame scaffold

PRO-LYS-LYS-LYS-ARG-LYS-VAL-GLU-ASP-*PRO-TYR-CYS

CAS105425-98-7

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(3S)-3-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamidopropanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-4-oxobutanoic acid;2,2,2-trifluoroacetic acid

InChIKey

BJXCBUYCBKDVID-SBLBPKJYSA-N

SMILES

C[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C=O)NC(=O)C.C(=O)(C(F)(F)F)O

Synonyms (3)

—

Sourcing Cell-permeable Caspase-1 Inhibitor I trifluoroacetate salt?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→